Live Breaking News & Updates on Armata Pharmaceuticals

Stay updated with breaking news from Armata pharmaceuticals. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Armata Pharmaceuticals' (ARMP) "Buy" Rating Reiterated at HC Wainwright

Armata Pharmaceuticals' (ARMP) "Buy" Rating Reiterated at HC Wainwright
dailypolitical.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dailypolitical.com Daily Mail and Mail on Sunday newspapers.

Seacrest Wealth Management , Armata Pharmaceuticals , News Ratings For Armata Pharmaceuticals Daily , Armata Pharmaceuticals Trading Down , Exchange Commission , Institutional Trading Of Armata Pharmaceuticals , Armata Pharmaceuticals Inc , Get Free Report , Pharmaceuticals Trading Down , Crest Wealth Management , Free Report , Armata Pharmaceuticals Daily ,

Armata Pharmaceuticals (NYSEAMERICAN:ARMP) Receives "Buy" Rating from HC Wainwright

HC Wainwright reissued their buy rating on shares of Armata Pharmaceuticals (NYSEAMERICAN:ARMP – Free Report) in a research report released on Friday morning, Benzinga reports. They currently have a $7.00 price target on the stock. Armata Pharmaceuticals Stock Performance NYSEAMERICAN ARMP opened at $3.91 on Friday. The company has a market cap of $141.35 million, […] ....

Armata Pharmaceuticals Inc , Armata Pharmaceuticals , Armata Pharmaceuticals Company Profile , News Ratings For Armata Pharmaceuticals Daily , Northern Trust Corp , Renaissance Technologies , Armata Pharmaceuticals Stock Performance , Vanguard Group Inc , Free Report , Street Group , Get Free Report , Armata Pharmaceuticals Daily ,

Armata Pharmaceuticals' (ARMP) "Buy" Rating Reiterated at HC Wainwright

HC Wainwright restated their buy rating on shares of Armata Pharmaceuticals (NYSEAMERICAN:ARMP – Free Report) in a research report sent to investors on Friday, Benzinga reports. They currently have a $7.00 price target on the stock. Armata Pharmaceuticals Stock Up 1.4 % Shares of ARMP opened at $3.74 on Friday. The stock has a market […] ....

Vanguard Group Inc , Hedge Funds Weigh In On Armata Pharmaceuticals , Armata Pharmaceuticals Stock , News Ratings For Armata Pharmaceuticals Daily , Armata Pharmaceuticals Inc , Renaissance Technologies , Armata Pharmaceuticals , Northern Trust Corp , Free Report , Trust Corp , Jane Street Group , Get Free Report , Armata Pharmaceuticals Daily ,

Innoviva Reports Fourth Quarter and Full Year 2023 Financial Results; Highlights Recent Company Progress

Core royalty platform on track; received GSK royalties of $69.6 million for fourth quarter

Achieved net product revenues of $19.7 million for the fourth quarter of 2023 representing 35% year on. ....

Pavel Raifeld , Matthew Ronsheim , Armata Pharmaceuticals , Jolla Pharmaceutical Company , Securities Exchange , Glaxo Group Limited , Innoviva Inc , Drug Administration , Global Antibiotic Research Development Partnership , Exchange Commission , Innoviva Specialty Therapeutics , Chief Executive Officer , Product Sales , Global Antibiotic Research , Development Partnership , New Drug Application , Lancet Infectious Diseases , Strategic Healthcare , Gate Neurosciences , Entasis Therapeutics , Private Securities Litigation Reform Act , Securities Exchange Act , Financial Condition , Annual Report , Quarterly Reports , Consolidated Statements ,

How bacteria-fighting viruses could go mainstream

Viruses called phages hold enormous promise as a way to fight infection, but don’t expect to see them in the clinic soon. ....

United States , Rio De Janeiro , Estado Do Rio , Republic Of Georgia , Jessica Hamzelou , Lynn Cole , Paroma Basu , Charlotte Jee , Emily Mullin , Steffanie Strathdee , Deborah Birx , Madison Stellfox , Tom Patterson , Alexander Sulakvelidze , Drug Administration , Washington Post , University Of Pittsburgh , Armata Pharmaceuticals , Daria Van Tyne , Van Tyne , Los Angeles Based ,